The global market for Intravenous Analgesics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Intravenous Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Intravenous Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Intravenous Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Intravenous Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Intravenous Analgesics players cover Abbott Laboratories, AbbVie Inc., Bayer AG, Eli Lilly and Company and endo pharmaceuticals, Glaxosmithkline plc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Intravenous Analgesics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Intravenous Analgesics market, with both quantitative and qualitative data, to help readers understand how the Intravenous Analgesics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Intravenous Analgesics market and forecasts the market size by Type (Non opioids and Opioids,), by Application (Hospital, Pharmacy and Family,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Non opioids
Opioids
Segmentation by application
Hospital
Pharmacy
Family
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott Laboratories
AbbVie Inc.
Bayer AG
Eli Lilly and Company
endo pharmaceuticals, Glaxosmithkline plc
johnson and johnson md&d
Pfizer, Inc.
Reckitt Benckiser Group
Sanofi
Chapter Introduction
Chapter 1: Scope of Intravenous Analgesics, Research Methodology, etc.
Chapter 2: Executive Summary, global Intravenous Analgesics market size (sales and revenue) and CAGR, Intravenous Analgesics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Intravenous Analgesics sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Intravenous Analgesics sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Intravenous Analgesics market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Abbott Laboratories, AbbVie Inc., Bayer AG, Eli Lilly and Company, endo pharmaceuticals, Glaxosmithkline plc, johnson and johnson md&d, Pfizer, Inc., Reckitt Benckiser Group and Sanofi, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous Analgesics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Intravenous Analgesics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Intravenous Analgesics by Country/Region, 2017, 2022 & 2028
2.2 Intravenous Analgesics Segment by Type
2.2.1 Non opioids
2.2.2 Opioids
2.3 Intravenous Analgesics Sales by Type
2.3.1 Global Intravenous Analgesics Sales Market Share by Type (2017-2022)
2.3.2 Global Intravenous Analgesics Revenue and Market Share by Type (2017-2022)
2.3.3 Global Intravenous Analgesics Sale Price by Type (2017-2022)
2.4 Intravenous Analgesics Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Family
2.5 Intravenous Analgesics Sales by Application
2.5.1 Global Intravenous Analgesics Sale Market Share by Application (2017-2022)
2.5.2 Global Intravenous Analgesics Revenue and Market Share by Application (2017-2022)
2.5.3 Global Intravenous Analgesics Sale Price by Application (2017-2022)
3 Global Intravenous Analgesics by Company
3.1 Global Intravenous Analgesics Breakdown Data by Company
3.1.1 Global Intravenous Analgesics Annual Sales by Company (2020-2022)
3.1.2 Global Intravenous Analgesics Sales Market Share by Company (2020-2022)
3.2 Global Intravenous Analgesics Annual Revenue by Company (2020-2022)
3.2.1 Global Intravenous Analgesics Revenue by Company (2020-2022)
3.2.2 Global Intravenous Analgesics Revenue Market Share by Company (2020-2022)
3.3 Global Intravenous Analgesics Sale Price by Company
3.4 Key Manufacturers Intravenous Analgesics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Analgesics Product Location Distribution
3.4.2 Players Intravenous Analgesics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Intravenous Analgesics by Geographic Region
4.1 World Historic Intravenous Analgesics Market Size by Geographic Region (2017-2022)
4.1.1 Global Intravenous Analgesics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Intravenous Analgesics Annual Revenue by Geographic Region
4.2 World Historic Intravenous Analgesics Market Size by Country/Region (2017-2022)
4.2.1 Global Intravenous Analgesics Annual Sales by Country/Region (2017-2022)
4.2.2 Global Intravenous Analgesics Annual Revenue by Country/Region
4.3 Americas Intravenous Analgesics Sales Growth
4.4 APAC Intravenous Analgesics Sales Growth
4.5 Europe Intravenous Analgesics Sales Growth
4.6 Middle East & Africa Intravenous Analgesics Sales Growth
5 Americas
5.1 Americas Intravenous Analgesics Sales by Country
5.1.1 Americas Intravenous Analgesics Sales by Country (2017-2022)
5.1.2 Americas Intravenous Analgesics Revenue by Country (2017-2022)
5.2 Americas Intravenous Analgesics Sales by Type
5.3 Americas Intravenous Analgesics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Analgesics Sales by Region
6.1.1 APAC Intravenous Analgesics Sales by Region (2017-2022)
6.1.2 APAC Intravenous Analgesics Revenue by Region (2017-2022)
6.2 APAC Intravenous Analgesics Sales by Type
6.3 APAC Intravenous Analgesics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intravenous Analgesics by Country
7.1.1 Europe Intravenous Analgesics Sales by Country (2017-2022)
7.1.2 Europe Intravenous Analgesics Revenue by Country (2017-2022)
7.2 Europe Intravenous Analgesics Sales by Type
7.3 Europe Intravenous Analgesics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous Analgesics by Country
8.1.1 Middle East & Africa Intravenous Analgesics Sales by Country (2017-2022)
8.1.2 Middle East & Africa Intravenous Analgesics Revenue by Country (2017-2022)
8.2 Middle East & Africa Intravenous Analgesics Sales by Type
8.3 Middle East & Africa Intravenous Analgesics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Analgesics
10.3 Manufacturing Process Analysis of Intravenous Analgesics
10.4 Industry Chain Structure of Intravenous Analgesics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Analgesics Distributors
11.3 Intravenous Analgesics Customer
12 World Forecast Review for Intravenous Analgesics by Geographic Region
12.1 Global Intravenous Analgesics Market Size Forecast by Region
12.1.1 Global Intravenous Analgesics Forecast by Region (2023-2028)
12.1.2 Global Intravenous Analgesics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravenous Analgesics Forecast by Type
12.7 Global Intravenous Analgesics Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Intravenous Analgesics Product Offered
13.1.3 Abbott Laboratories Intravenous Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 AbbVie Inc.
13.2.1 AbbVie Inc. Company Information
13.2.2 AbbVie Inc. Intravenous Analgesics Product Offered
13.2.3 AbbVie Inc. Intravenous Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AbbVie Inc. Main Business Overview
13.2.5 AbbVie Inc. Latest Developments
13.3 Bayer AG
13.3.1 Bayer AG Company Information
13.3.2 Bayer AG Intravenous Analgesics Product Offered
13.3.3 Bayer AG Intravenous Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer AG Main Business Overview
13.3.5 Bayer AG Latest Developments
13.4 Eli Lilly and Company
13.4.1 Eli Lilly and Company Company Information
13.4.2 Eli Lilly and Company Intravenous Analgesics Product Offered
13.4.3 Eli Lilly and Company Intravenous Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Eli Lilly and Company Main Business Overview
13.4.5 Eli Lilly and Company Latest Developments
13.5 endo pharmaceuticals, Glaxosmithkline plc
13.5.1 endo pharmaceuticals, Glaxosmithkline plc Company Information
13.5.2 endo pharmaceuticals, Glaxosmithkline plc Intravenous Analgesics Product Offered
13.5.3 endo pharmaceuticals, Glaxosmithkline plc Intravenous Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 endo pharmaceuticals, Glaxosmithkline plc Main Business Overview
13.5.5 endo pharmaceuticals, Glaxosmithkline plc Latest Developments
13.6 johnson and johnson md&d
13.6.1 johnson and johnson md&d Company Information
13.6.2 johnson and johnson md&d Intravenous Analgesics Product Offered
13.6.3 johnson and johnson md&d Intravenous Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 johnson and johnson md&d Main Business Overview
13.6.5 johnson and johnson md&d Latest Developments
13.7 Pfizer, Inc.
13.7.1 Pfizer, Inc. Company Information
13.7.2 Pfizer, Inc. Intravenous Analgesics Product Offered
13.7.3 Pfizer, Inc. Intravenous Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pfizer, Inc. Main Business Overview
13.7.5 Pfizer, Inc. Latest Developments
13.8 Reckitt Benckiser Group
13.8.1 Reckitt Benckiser Group Company Information
13.8.2 Reckitt Benckiser Group Intravenous Analgesics Product Offered
13.8.3 Reckitt Benckiser Group Intravenous Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Reckitt Benckiser Group Main Business Overview
13.8.5 Reckitt Benckiser Group Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Intravenous Analgesics Product Offered
13.9.3 Sanofi Intravenous Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Intravenous Analgesics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Intravenous Analgesics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Non opioids
Table 4. Major Players of Opioids
Table 5. Global Intravenous Analgesics Sales by Type (2017-2022) & (K Units)
Table 6. Global Intravenous Analgesics Sales Market Share by Type (2017-2022)
Table 7. Global Intravenous Analgesics Revenue by Type (2017-2022) & ($ million)
Table 8. Global Intravenous Analgesics Revenue Market Share by Type (2017-2022)
Table 9. Global Intravenous Analgesics Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Intravenous Analgesics Sales by Application (2017-2022) & (K Units)
Table 11. Global Intravenous Analgesics Sales Market Share by Application (2017-2022)
Table 12. Global Intravenous Analgesics Revenue by Application (2017-2022)
Table 13. Global Intravenous Analgesics Revenue Market Share by Application (2017-2022)
Table 14. Global Intravenous Analgesics Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Intravenous Analgesics Sales by Company (2020-2022) & (K Units)
Table 16. Global Intravenous Analgesics Sales Market Share by Company (2020-2022)
Table 17. Global Intravenous Analgesics Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Intravenous Analgesics Revenue Market Share by Company (2020-2022)
Table 19. Global Intravenous Analgesics Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Intravenous Analgesics Producing Area Distribution and Sales Area
Table 21. Players Intravenous Analgesics Products Offered
Table 22. Intravenous Analgesics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Intravenous Analgesics Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Intravenous Analgesics Sales Market Share Geographic Region (2017-2022)
Table 27. Global Intravenous Analgesics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Intravenous Analgesics Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Intravenous Analgesics Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Intravenous Analgesics Sales Market Share by Country/Region (2017-2022)
Table 31. Global Intravenous Analgesics Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Intravenous Analgesics Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Intravenous Analgesics Sales by Country (2017-2022) & (K Units)
Table 34. Americas Intravenous Analgesics Sales Market Share by Country (2017-2022)
Table 35. Americas Intravenous Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Intravenous Analgesics Revenue Market Share by Country (2017-2022)
Table 37. Americas Intravenous Analgesics Sales by Type (2017-2022) & (K Units)
Table 38. Americas Intravenous Analgesics Sales Market Share by Type (2017-2022)
Table 39. Americas Intravenous Analgesics Sales by Application (2017-2022) & (K Units)
Table 40. Americas Intravenous Analgesics Sales Market Share by Application (2017-2022)
Table 41. APAC Intravenous Analgesics Sales by Region (2017-2022) & (K Units)
Table 42. APAC Intravenous Analgesics Sales Market Share by Region (2017-2022)
Table 43. APAC Intravenous Analgesics Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Intravenous Analgesics Revenue Market Share by Region (2017-2022)
Table 45. APAC Intravenous Analgesics Sales by Type (2017-2022) & (K Units)
Table 46. APAC Intravenous Analgesics Sales Market Share by Type (2017-2022)
Table 47. APAC Intravenous Analgesics Sales by Application (2017-2022) & (K Units)
Table 48. APAC Intravenous Analgesics Sales Market Share by Application (2017-2022)
Table 49. Europe Intravenous Analgesics Sales by Country (2017-2022) & (K Units)
Table 50. Europe Intravenous Analgesics Sales Market Share by Country (2017-2022)
Table 51. Europe Intravenous Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Intravenous Analgesics Revenue Market Share by Country (2017-2022)
Table 53. Europe Intravenous Analgesics Sales by Type (2017-2022) & (K Units)
Table 54. Europe Intravenous Analgesics Sales Market Share by Type (2017-2022)
Table 55. Europe Intravenous Analgesics Sales by Application (2017-2022) & (K Units)
Table 56. Europe Intravenous Analgesics Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Intravenous Analgesics Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Intravenous Analgesics Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Intravenous Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Intravenous Analgesics Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Intravenous Analgesics Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Intravenous Analgesics Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Intravenous Analgesics Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Intravenous Analgesics Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Intravenous Analgesics
Table 66. Key Market Challenges & Risks of Intravenous Analgesics
Table 67. Key Industry Trends of Intravenous Analgesics
Table 68. Intravenous Analgesics Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Intravenous Analgesics Distributors List
Table 71. Intravenous Analgesics Customer List
Table 72. Global Intravenous Analgesics Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Intravenous Analgesics Sales Market Forecast by Region
Table 74. Global Intravenous Analgesics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Intravenous Analgesics Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Intravenous Analgesics Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Intravenous Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Intravenous Analgesics Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Intravenous Analgesics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Intravenous Analgesics Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Intravenous Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Intravenous Analgesics Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Intravenous Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Intravenous Analgesics Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Intravenous Analgesics Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Intravenous Analgesics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Intravenous Analgesics Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Intravenous Analgesics Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Intravenous Analgesics Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Intravenous Analgesics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Intravenous Analgesics Revenue Market Share Forecast by Application (2023-2028)
Table 92. Abbott Laboratories Basic Information, Intravenous Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Laboratories Intravenous Analgesics Product Offered
Table 94. Abbott Laboratories Intravenous Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Abbott Laboratories Main Business
Table 96. Abbott Laboratories Latest Developments
Table 97. AbbVie Inc. Basic Information, Intravenous Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 98. AbbVie Inc. Intravenous Analgesics Product Offered
Table 99. AbbVie Inc. Intravenous Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. AbbVie Inc. Main Business
Table 101. AbbVie Inc. Latest Developments
Table 102. Bayer AG Basic Information, Intravenous Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 103. Bayer AG Intravenous Analgesics Product Offered
Table 104. Bayer AG Intravenous Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Bayer AG Main Business
Table 106. Bayer AG Latest Developments
Table 107. Eli Lilly and Company Basic Information, Intravenous Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 108. Eli Lilly and Company Intravenous Analgesics Product Offered
Table 109. Eli Lilly and Company Intravenous Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Eli Lilly and Company Main Business
Table 111. Eli Lilly and Company Latest Developments
Table 112. endo pharmaceuticals, Glaxosmithkline plc Basic Information, Intravenous Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 113. endo pharmaceuticals, Glaxosmithkline plc Intravenous Analgesics Product Offered
Table 114. endo pharmaceuticals, Glaxosmithkline plc Intravenous Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. endo pharmaceuticals, Glaxosmithkline plc Main Business
Table 116. endo pharmaceuticals, Glaxosmithkline plc Latest Developments
Table 117. johnson and johnson md&d Basic Information, Intravenous Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 118. johnson and johnson md&d Intravenous Analgesics Product Offered
Table 119. johnson and johnson md&d Intravenous Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. johnson and johnson md&d Main Business
Table 121. johnson and johnson md&d Latest Developments
Table 122. Pfizer, Inc. Basic Information, Intravenous Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 123. Pfizer, Inc. Intravenous Analgesics Product Offered
Table 124. Pfizer, Inc. Intravenous Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Pfizer, Inc. Main Business
Table 126. Pfizer, Inc. Latest Developments
Table 127. Reckitt Benckiser Group Basic Information, Intravenous Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 128. Reckitt Benckiser Group Intravenous Analgesics Product Offered
Table 129. Reckitt Benckiser Group Intravenous Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Reckitt Benckiser Group Main Business
Table 131. Reckitt Benckiser Group Latest Developments
Table 132. Sanofi Basic Information, Intravenous Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 133. Sanofi Intravenous Analgesics Product Offered
Table 134. Sanofi Intravenous Analgesics Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Sanofi Main Business
Table 136. Sanofi Latest Developments
List of Figures
Figure 1. Picture of Intravenous Analgesics
Figure 2. Intravenous Analgesics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Analgesics Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Intravenous Analgesics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Intravenous Analgesics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Non opioids
Figure 10. Product Picture of Opioids
Figure 11. Global Intravenous Analgesics Sales Market Share by Type in 2021
Figure 12. Global Intravenous Analgesics Revenue Market Share by Type (2017-2022)
Figure 13. Intravenous Analgesics Consumed in Hospital
Figure 14. Global Intravenous Analgesics Market: Hospital (2017-2022) & (K Units)
Figure 15. Intravenous Analgesics Consumed in Pharmacy
Figure 16. Global Intravenous Analgesics Market: Pharmacy (2017-2022) & (K Units)
Figure 17. Intravenous Analgesics Consumed in Family
Figure 18. Global Intravenous Analgesics Market: Family (2017-2022) & (K Units)
Figure 19. Global Intravenous Analgesics Sales Market Share by Application (2017-2022)
Figure 20. Global Intravenous Analgesics Revenue Market Share by Application in 2021
Figure 21. Intravenous Analgesics Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Intravenous Analgesics Revenue Market Share by Company in 2021
Figure 23. Global Intravenous Analgesics Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Intravenous Analgesics Revenue Market Share by Geographic Region in 2021
Figure 25. Global Intravenous Analgesics Sales Market Share by Region (2017-2022)
Figure 26. Global Intravenous Analgesics Revenue Market Share by Country/Region in 2021
Figure 27. Americas Intravenous Analgesics Sales 2017-2022 (K Units)
Figure 28. Americas Intravenous Analgesics Revenue 2017-2022 ($ Millions)
Figure 29. APAC Intravenous Analgesics Sales 2017-2022 (K Units)
Figure 30. APAC Intravenous Analgesics Revenue 2017-2022 ($ Millions)
Figure 31. Europe Intravenous Analgesics Sales 2017-2022 (K Units)
Figure 32. Europe Intravenous Analgesics Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Intravenous Analgesics Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Intravenous Analgesics Revenue 2017-2022 ($ Millions)
Figure 35. Americas Intravenous Analgesics Sales Market Share by Country in 2021
Figure 36. Americas Intravenous Analgesics Revenue Market Share by Country in 2021
Figure 37. United States Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Intravenous Analgesics Sales Market Share by Region in 2021
Figure 42. APAC Intravenous Analgesics Revenue Market Share by Regions in 2021
Figure 43. China Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Intravenous Analgesics Sales Market Share by Country in 2021
Figure 50. Europe Intravenous Analgesics Revenue Market Share by Country in 2021
Figure 51. Germany Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Intravenous Analgesics Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Intravenous Analgesics Revenue Market Share by Country in 2021
Figure 58. Egypt Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Intravenous Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Intravenous Analgesics in 2021
Figure 64. Manufacturing Process Analysis of Intravenous Analgesics
Figure 65. Industry Chain Structure of Intravenous Analgesics
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)